Literature DB >> 26033989

Giant cell tumor of the pelvis: a systematic review.

Kai Zheng1, Zhen Wang2, Su-jia Wu3, Zhao-ming Ye4, Song-feng Xu1, Ming Xu1, Yong-cheng Hu5, Xiu-chun Yu1.   

Abstract

This is a systematic review of articles concerning the morbidity, recurrence rate, treatment and treatment complications of pelvic giant cell tumors (GCTs). The key words "giant cell tumor, pelvis" were used to identify articles which included data on patients with pelvic GCTs in English and Chinese databases of published reports from 1949-2012. The articles were filtered by title, abstract and full text. Thirty-eight articles and 165 patients were identified for this review. Data on all identified patients were studies; data in different articles on the same patients was not used repeatedly. The following patient data were collected where possible and subjected to systematic analysis; age, location of GCT, treatment, follow-up, complications, recurrence and whether alive or dead. The mean age of onset was 33.2 years (range, 14-73 years), the peak ages of onset being between 21 and 40 years. A pronounced sex difference was identified, the male : female ratio being 1:1.7. The acetabulum was the commonest area for pelvic GCTs. Forty-eight tumors were primarily located in the iliac, 60 in the acetabular and 31 in the ischiopubic area. Twenty-seven patients experienced complications of treatment. Patients who had been treated by wide resection had the most complications; these included incisional infection and delayed healing of incisions. Local recurrence was common, having occurred in 39/158 patients (24.6%), comprising 24/72 (33.3%) who had undergone intralesional surgery only; 9/20 (45.0%) who had undergone radiotherapy only; 1/51 (2.0%) who had undergone wide resection; and 5/14 patients (35.7%) who had undergone radiation therapy or cryotherapy plus intralesional surgery. Mortality was low (3.2%, 5/158). Pelvic GCT is not common, the acetabular area appears to the most frequent site and the peak age is the third and fourth decades. Although the recurrence rate is high for all pelvic GCTs, the mortality is low. Treatment has a critical influence on recurrence. In spite of the associated complications, the lower local recurrence rate makes wide resection a reasonable option for patients with extensive and/or aggressive GCTs.
© 2015 Chinese Orthopaedic Association and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Giant cell tumors; Pelvis; Systematic review

Mesh:

Year:  2015        PMID: 26033989      PMCID: PMC6583480          DOI: 10.1111/os.12174

Source DB:  PubMed          Journal:  Orthop Surg        ISSN: 1757-7853            Impact factor:   2.071


  7 in total

1.  Multidisciplinary, articular surface-preserving treatment strategy for locally aggressive epithelioid hemangioma of the acetabulum employing serial bland transarterial embolization.

Authors:  Salim Abboud; Aashish Bhatt; Irina Pateva; Shahrazad Saab; Meera Hameed; John Healey; Patrick Getty
Journal:  Skeletal Radiol       Date:  2022-01-10       Impact factor: 2.199

2.  Sex Differences in the Recurrence Rate and Risk Factors for Primary Giant Cell Tumors Around the Knee in China.

Authors:  Yongcheng Hu; Liming Zhao; Huilin Zhang; Xiuchun Yu; Zhen Wang; Zhaoming Ye; Sujia Wu; Shibing Guo; Guochuan Zhang; Jinghua Wang; Xianjia Ning
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

3.  An acetabular-preserving procedure for pelvic giant cell tumor involving partial acetabulum.

Authors:  Cong Xiao; Yong Zhou; Wenli Zhang; Yi Luo; Chongqi Tu
Journal:  World J Surg Oncol       Date:  2017-11-13       Impact factor: 2.754

4.  Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.

Authors:  Run-Zi Zhang; Tian-Xiao Ma; Dian-Wen Qi; Ming Zhao; Tongyu Hu; Guo-Chuan Zhang
Journal:  Orthop Surg       Date:  2019-11-25       Impact factor: 2.071

5.  A 15 year-old-girl with persistent leg pain diagnosed as a giant cell tumor of the tibial diaphysis: A case report and review of the literature.

Authors:  Hasan Masud; Prashant Yadav; Sushmita Yadav; Mohammed Kamal
Journal:  Int J Surg Case Rep       Date:  2022-09-20

Review 6.  Large giant cell tumor of the posterior iliac bone - an atypical location. A case report and literature review.

Authors:  Cosmin Ioan Faur; Daniel Laurenţiu Pop; Andrei Gheorghe Marius Motoc; Roxana Folescu; Mirela Loredana Grigoraş; Daniela Gurguş; Carmen Lăcrămioara Zamfir; Mihaela Iacob; Dinu Vermeşan; Bogdan Nicolae Deleanu; Horia George Hărăguş; Daniel Claudiu Maliţa; Ahmed Abu-Awwad; Ion Lucian Ghiga; Mariana Tudoran
Journal:  Rom J Morphol Embryol       Date:  2020       Impact factor: 1.033

7.  Study of imaging changes following preoperative denosumab for giant cell tumor of bone.

Authors:  Yongkun Yang; Hairong Xu; Weifeng Liu; Xiaohui Niu
Journal:  J Bone Oncol       Date:  2021-12-31       Impact factor: 4.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.